397 related articles for article (PubMed ID: 36367195)
1. Role of N
Ye T; Wang J; Zhao H; Zhao G; Li P
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36367195
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
3. [Current research status and progress in comprehensive diagnosis and treatment of pancreatic cancer in the era of targeted therapy].
Zhang ZK; Yang YM
Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):22-26. PubMed ID: 31902165
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.
Badheeb M; Abdelrahim A; Esmail A; Umoru G; Abboud K; Al-Najjar E; Rasheed G; Alkhulaifawi M; Abudayyeh A; Abdelrahim M
Curr Oncol; 2022 Nov; 29(11):8693-8719. PubMed ID: 36421339
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the management of pancreatic adenocarcinoma.
Karakas Y; Lacin S; Yalcin S
Expert Rev Anticancer Ther; 2018 Jan; 18(1):51-62. PubMed ID: 29125367
[TBL] [Abstract][Full Text] [Related]
6. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and treatment of pancreatic cancer in China.
Guo X; Cui Z
Pancreas; 2005 Jul; 31(1):13-22. PubMed ID: 15968242
[TBL] [Abstract][Full Text] [Related]
8. Potential Roles of the Gut Microbiota in Pancreatic Carcinogenesis and Therapeutics.
Yang Q; Zhang J; Zhu Y
Front Cell Infect Microbiol; 2022; 12():872019. PubMed ID: 35463649
[TBL] [Abstract][Full Text] [Related]
9. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.
Du Y; Liu M; Gao J; Li Z
Cancer Biother Radiopharm; 2013 Jun; 28(5):361-9. PubMed ID: 23621126
[TBL] [Abstract][Full Text] [Related]
10. Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer.
Wu H; Chen X; Ji J; Zhou R; Liu J; Ni W; Qu L; Ni H; Ni R; Bao B; Xiao M
Genet Test Mol Biomarkers; 2019 Mar; 23(3):215-222. PubMed ID: 30793953
[TBL] [Abstract][Full Text] [Related]
11. Research progress on circularRNAs in pancreatic cancer: emerging but promising.
Wang YZ; An Y; Li BQ; Lu J; Guo JC
Cancer Biol Ther; 2019; 20(9):1163-1171. PubMed ID: 31138014
[TBL] [Abstract][Full Text] [Related]
12. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.
Khan MA; Azim S; Zubair H; Bhardwaj A; Patel GK; Khushman M; Singh S; Singh AP
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383487
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma.
Lotfi Z; Najjary S; Lotfi F; Amini M; Baghbanzadeh A; Rashid DJ; Asl ER; Baradaran B; Mokhtarzadeh A
Eur J Pharmacol; 2021 Jun; 901():174006. PubMed ID: 33711308
[TBL] [Abstract][Full Text] [Related]
14. Roles of Dclk1 in the pathogenesis, diagnosis, prognosis and treatment of pancreatic cancer: A review.
Wang Y; Yi J; Liu X
Expert Rev Gastroenterol Hepatol; 2022 Jan; 16(1):13-19. PubMed ID: 34937474
[TBL] [Abstract][Full Text] [Related]
15. 1996 Comfort Symposium on Pancreatic Carcinogenesis.
Urrutia R; Miller LJ; DiMagno EP
Pancreas; 1998 Jan; 16(1):1-5. PubMed ID: 9436855
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer.
Chang ZY; Sun R; Ma YS; Fu D; Lai XL; Li YS; Wang XH; Zhang XP; Lv ZW; Cong XL; Li WP
Cell Biochem Funct; 2014 Apr; 32(3):258-67. PubMed ID: 24122964
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer: the role of molecular markers in diagnosis and management.
Lowery MA; O'Reilly EM
Clin Adv Hematol Oncol; 2011 Dec; 9(12):900-8. PubMed ID: 22252658
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment.
Rong Z; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
Theranostics; 2021; 11(6):2755-2769. PubMed ID: 33456571
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.
Karmakar S; Kaushik G; Nimmakayala R; Rachagani S; Ponnusamy MP; Batra SK
Semin Cancer Biol; 2019 Feb; 54():63-71. PubMed ID: 29199014
[TBL] [Abstract][Full Text] [Related]
20. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
